CompletedPHASE1, PHASE2NCT01340482

A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia

Studying X-linked hypophosphatemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Kyowa Kirin Co., Ltd.
Principal Investigator
Amy Zhang, PhD
Kyowa Hakko Kirin Pharma, Inc.
Intervention
KRN23(drug)
Enrollment
29 enrolled
Eligibility
18 years · All sexes
Timeline
20112013

Study locations (6)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01340482 on ClinicalTrials.gov

Other trials for X-linked hypophosphatemia

Additional recruiting or active studies for the same condition.

See all trials for X-linked hypophosphatemia

← Back to all trials